Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 213-221

  Rice, Annette B ^a   Moomaw, Cindy R ^a   Morgan, Daniel L ^a   Bonner, James C ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; HYDROXYPROLINE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; MALE; MESENCHYME CELL; MITOGENESIS; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0032986505     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65115-2     Document Type: Article

References (40)

1. Woodcock-Mitchell J, Adler KB, Low RB: Immunohistochemical identification of cell types in normal and bleomycin-induced fibrotic rat lung. Am Rev Respir Dis 1984, 130:910-916
2. Coin PG, Osornio-Vargas AR, Roggli VL, Brody AR: Pulmonary fibro-genesis after three consecutive inhalation exposures to chrysotile asbestos. Am J Respir Crit Care Med 1996, 154:1511-1519
3. Driscoll KE, Maurer JK, Poynter J, Higgens J, Asquith T, Miller NS: Stimulation of rat alveolar macrophage fibronectin release in a cadmium chloride model of lung injury and fibrosis. Toxicol Appl Pharmacol 1992, 116:30-37
4. Bonner JC, lindroos PM, Rice AB, Moomaw CR, Morgan DL: Induction of PDGF receptor-α in rat myofibroblasts during pulmonary fibro-genesis in vivo. Am J Physiol 1998, 274:L72-L80
5. Khalil N, Bereznay O, Sporn M, Greenberg AH: Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989, 170:727-734
6. Broekelmann TJ, Limper AH, Colby TV, McDonald JA: Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991, 88:6642-6646
7. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol 1994, 145:114-125
8. Antoniades HN, Bravo MA, Avila RE, Galanopoulos T, Neville-Golden J, Maxwell M, Selman M: Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 1990, 86:1055-1064
9. Hertz MI, Henke CA, Nakhleh RE, Harmon KR, Marinelli WA, Fox JMK, Kubo SH, Shumway SJ, Bolman RM, Bitterman PB: Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc Natl Acad Sci USA 1992, 89:10385-10389
10. Liu J-Y, Morris GF, Lei W-H, Hart CE, Lasky JA, Brody AR: Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats. Am J Respir Cell Mol Biol 1997, 17:129-140
11. Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR, Raghu G, Hudson LD, and Clark JG: Elevated transforming growth factor-α levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:424-430
12. Liu J-Y. Morris GF, Lei W-H, Corti M, Brody AR: Up-regulated expression of transforming growth factor-α in the bronchiolar-alveolar duct regions of asbestos exposed rats. Am J Pathol 1996, 149:205-217
13. Madtes DK, Busby HK, Strandjord TP, Clark JG: Expression of transforming growth factor-α and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 1994, 1:540-541
14. Heldin C-H, Westermark B: Signal transduction by the receptors for platelet-derived growth factor. J Cell Sci 1990, 96:193-196
15. Boni-Schnetzler M, Pilch PF: Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci USA 1987 84:7832-7836
16. Bell GI, Fong NM, Stempien MM, Wormsted MA, Caput D, Ku L, Urdea MS, Rall LB, Sanchez-Pescador R: Human epidermal growth factor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res 1986, 14:8427-8446
17. Madtes DK, Raines EW, Sakariassen KS, Assoian RK, Sporn MB, Bell Gl, Ross R: Induction of transforming growth factor-α in activated human alveolar macrophages. Cell 1988, 53:285-293
18. Higashiyama S, Abraham JA, Miller J, Fiddles JC. Klagsbrun M: A Heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991, 251:936-942
19. Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ, Bowen-Pope DF: Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 1989. 264:8771-8778
20. Claesson-Welsh L: Platelet-derived growth factor receptor signals. J Biol Chem 1994, 269:32023-32026
21. Secrist JP, Seghal I, Powis G, Abraham RT: Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine. J Biol Chem 1990, 265:20394-20400
22. Levitzki A, Gazit A: Tyrosine kinase inhibition: an approach to drug development. Science 1995, 267:1782-1788
23. Kovalenko M, Ronnstrand L, Heldin C-H, Loutchenkov M, Gazit A, Levitzki A, Bohmer FD: Phosphorylation site-specific inhibition of platelet-derived growth factor β-receptor autophosphorylation by the receptor blocking tyrphostin AG1296. Biochemistry 1997, 36:6260-6269
24. Buchdunger E, Trinks U. Mett H, Regenass U, Muller M, Meyer T, McGlynn E, Pinna LA, Traxler P, Lydon NB: 4,5-Dianilinophthalimide: a protein tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent in vivo antitumor activity. Proc Natl Acad Sci USA 1994, 91:2334-2338
25. Buchdunger E. Zimmerman J, Mett H, Meyer T, Muller M, Regenass U, Lydon NB: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci USA 1995, 92:2558-2562
26. Novogrodsky A, Vanichkin A, Patya M, Osherov N, Levitzki A: Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994, 264:1319-1322
27. Haschek WM, Klein-Szanto AJ, Last JA, Reiser KM, Witschi H: Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse. Lab Invest 1982, 46:438-439
28. Snyder LS, Hertz MI, Peterson MS, Harmon KR, Marinelli WA, Henke CA, Greenheck JR, Chen B, Bitterman PB: Acute lung injury: pathogenesis of intraalveolar fibrosis. J Clin Invest 1991, 88:663-673
29. Walsh J, Absher M, Kelley J: Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am J Respir Cell Mol Biol 1993, 9:637-644
30. Bonner JC, Osornio-Vargas AR, Badgett A, Brody AR: Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages. Am J Respir Cell Mol Biol 1991, 5:539-547
31. Banai S, Wolf Y, Golomb G, Pearle A, Waltenberger J, Fishbein I, Schneider A, Gazit A, Perez L, Huber R, Lazarovichi G, Rabinovich L, Levitzki L, Gertz SD: PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 1998, 97:1960-1969
32. Golomb G, Fishbein I, Banai S, Mishaly D, Moscovitz D, Gertz SD, Gazit A, Poradosu E, Levitzki A: Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis 1996, 125:171-182
33. Myllarniemi M, Calderon L, Lemstrom K, Buchdunger E, Hayry P: Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J 1997, 11:1119-1126
34. Ferns GA, Raines EW, Sprugel KH, Montani AS, Reidy MA, Ross R: Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253:1129-1132
35. Yi ES, Lee H, Yin S, Piquet P, Sarosi I, Kaufmann S, Tarpley J, Wang N-S, Ulich TR: Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am J Pathol 1996, 149:539-548
36. Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N, Kaneda Y, Kishimoto TA: Histologically distinctive interstitial pneumonia induced by overexpression of the interleukin-6, transforming growth factor β31. or platelet-derived growth factor B gene. Proc Natl Acad Sci USA 1995, 92:9570-9574
37. Bostrom H. Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Tornell J, Heath JK, Betsholtz C: PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveo-genesis. Cell 1996, 85:863-873
38. Bonner JC, Goodell AL, Coin PG, Brody AR: Chrysotile asbestos upregulates gene expression and production of α-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts. J Clin Invest 1993, 92:425-430
39. Zanella CL, Posada J, Tritton TR, Mossman BT: Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Res 1996, 56:5334-5338
40. Zhao Z, Tan Z, Diltz CD, You M, Fischer EH: Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem 1996, 36:22251-22255